Skip to content

Smart Device-based Cardiac Rehabilitation After Myocardial Intervention

Smart Device-based Cardiac Rehabilitation After Myocardial Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03926312
Acronym
SmartRehab
Enrollment
64
Registered
2019-04-24
Start date
2019-06-19
Completion date
2023-10-05
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

myocardial infarction, cardiac rehabilitation, smart device, remote monitoring, telemonitoring, low physical activity, risk factors control

Brief summary

The aim of this study is to evaluate the influence of cardiac rehabilitation based on smart band use and telemonitoring on functional capacity change and risk factors control among patients hospitalized for acute myocardial infarction.

Interventions

DEVICESmart device-based cardiac rehabilitation

A smart device coupled with remote monitoring will be used to increase physical activity of patients after myocardial infarction with a history of low physical activity.

Sponsors

Institute for Clinical and Experimental Medicine
CollaboratorOTHER_GOV
Charles University, Czech Republic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. Signed informed consent with the study 2. Men and women \>18 years of age 3. Patients ≥1 and ≤6 months after type I myocardial infarction 4. Physical inactivity before MI defined as the absence of moderate to vigorous exercise for at least 30 minutes 5 or more days a week

Exclusion criteria

1. Heart failure NYHA IIIB-IV 2. Planned coronary revascularization 3. Planned major surgery within the next 12 months 4. Inability to walk for any reason 5. Comorbidities that would preclude adherence to the rehabilitation program (e.g. arthrosis, active malignancy, major depression or other significant psychiatric disorder, cognitive impairment) - at the discretion of the physician 6. Life expectancy less than 12 months 7. Pregnancy 8. Inability to operate the smart-watch

Design outcomes

Primary

MeasureTime frameDescription
Functional capacity change3 months6-minute walk test distance and maximal oxygen consumption (VO2 max) change after 3 months of the intervention

Secondary

MeasureTime frameDescription
Body fat percentage3 monthsBody fat percentage change after 3 months of the intervention
Smoking cessation3 monthsSmoking cessation after 3 months of the intervention
Waist circumference3 monthsWaist circumference change after 3 months of the intervention
Blood pressure3 monthsBlood pressure change after 3 months of the intervention
Glycated hemoglobin3 monthsGlycated hemoglobin change after 3 months of the intervention
Lipid levels3 monthsLipid levels change after 3 months of the intervention

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026